Summary
This prediction ended on 11.07.18 with a price of €15.58. The BUY prediction by mohabbatein finished with a performance of 25.75%. mohabbatein has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | -3.440% | -3.440% | -50.962% | -72.257% |
| iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
| iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
| iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
| iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by mohabbatein for this prediction
In the thread Evotec AG diskutieren
Auskonsolidiert?
Schaut man sich die Kooperationen und Meilensteinzahlungen an, läuft es richtig rund für Evotec. Das hat in den letzten Monaten viele Anleger bewogen, herzhaft zuzugreifen. Von einem Niveau über 20 Euro ging es dann erstmal kräftig gen Süden. Nu scheint wieder etwas Ruhe einzukehren und man kann auf eine Wiederaufnahme des Aufwärtstrends mit einer kleinen Position spekulieren.
BUY.